Verastem (VSTM) Research & Development (2011 - 2026)
Verastem (VSTM) recorded quarterly Research & Development of $38.2 million in Q1 2026, up 20.66% quarter-over-quarter from $31.7 million in Q4 2025, and up 31.1% on a YoY basis from $29.2 million in Q1 2025.
Verastem (VSTM) Research & Development (2011 - 2026) Analysis & Trends
Verastem's Research & Development history runs 16 years deep, the most recent figure standing at $38.2 million for Q1 2026.
- In Q1 2026, Research & Development rose 31.1% year-over-year to $38.2 million; the TTM figure through Mar 2026 stood at $123.7 million (up 33.29% YoY), while the FY2025 annual figure was $114.6 million, up 40.9% from the prior year.
- Research & Development was $38.2 million for Q1 2026 at Verastem, up from $31.7 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $38.2 million in Q1 2026 to a low of $10.7 million in Q4 2022.
- Historically, Research & Development has averaged $20.4 million across 5 years, with a median of $18.1 million in 2024.
- Biggest YoY gain for Research & Development was 109.52% in 2023; the steepest drop was 13.4% in 2023.
- A 5-year view of Research & Development shows it stood at $10.7 million in 2022, then soared by 109.52% to $22.5 million in 2023, then retreated by 7.51% to $20.8 million in 2024, then surged by 52.2% to $31.7 million in 2025, then gained by 20.66% to $38.2 million in 2026.
- The last three Research & Development figures came in at $38.2 million (Q1 2026), $31.7 million (Q4 2025), and $29.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 38.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.22 Mn |
| Dec 31, 2025 | 31.67 Mn |
| Sep 30, 2025 | 28.99 Mn |
| Jun 30, 2025 | 24.79 Mn |
| Mar 31, 2025 | 29.15 Mn |
| Dec 31, 2024 | 20.81 Mn |
| Sep 30, 2024 | 24.75 Mn |
| Jun 30, 2024 | 18.06 Mn |
| Mar 31, 2024 | 17.71 Mn |
| Dec 31, 2023 | 22.50 Mn |
| Sep 30, 2023 | 13.95 Mn |
| Jun 30, 2023 | 12.89 Mn |
| Mar 31, 2023 | 12.02 Mn |
| Dec 31, 2022 | 10.74 Mn |
| Sep 30, 2022 | 11.29 Mn |
| Jun 30, 2022 | 14.89 Mn |
| Mar 31, 2022 | 13.64 Mn |
| Dec 31, 2021 | 11.40 Mn |
| Sep 30, 2021 | 9.33 Mn |
| Jun 30, 2021 | 9.73 Mn |